Matthew Harrison
Stock Analyst at Morgan Stanley
(3.48)
# 929
Out of 5,090 analysts
709
Total ratings
48.96%
Success rate
4.33%
Average return
Main Sectors:
Stocks Rated by Matthew Harrison
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ARGX argenx SE | Maintains: Overweight | $1,070 → $1,110 | $901.17 | +23.17% | 27 | Dec 4, 2025 | |
| PHVS Pharvaris | Maintains: Overweight | $37 → $41 | $26.42 | +55.19% | 16 | Dec 4, 2025 | |
| REGN Regeneron Pharmaceuticals | Downgrades: Equal-Weight | $767 | $718.36 | +6.77% | 57 | Dec 3, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Maintains: Equal-Weight | $8 → $4 | $1.39 | +187.77% | 5 | Nov 12, 2025 | |
| BMRN BioMarin Pharmaceutical | Maintains: Overweight | $104 → $98 | $53.40 | +83.52% | 23 | Oct 28, 2025 | |
| BIIB Biogen | Maintains: Equal-Weight | $144 → $149 | $181.30 | -17.82% | 55 | Oct 10, 2025 | |
| MRNA Moderna | Maintains: Equal-Weight | $31 → $32 | $27.70 | +15.52% | 26 | Oct 10, 2025 | |
| DNLI Denali Therapeutics | Maintains: Overweight | $33 → $30 | $19.96 | +50.30% | 13 | Aug 18, 2025 | |
| INSM Insmed | Downgrades: Equal-Weight | $112 → $126 | $204.00 | -38.24% | 19 | Aug 13, 2025 | |
| LEGN Legend Biotech | Maintains: Overweight | $81 → $83 | $28.13 | +195.06% | 13 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $6 → $4 | $0.70 | +474.14% | 6 | Aug 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $460 → $439 | $455.48 | -3.62% | 41 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $15 → $20 | $22.26 | -10.15% | 38 | Jul 29, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Positive | $215 | $186.39 | +15.35% | 1 | Jul 15, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $130 → $135 | $121.22 | +11.37% | 42 | Apr 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $6.2 → $6 | $3.17 | +89.27% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $5 | $1.41 | +254.61% | 5 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $160 → $178 | $139.33 | +27.75% | 1 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $56 | $30.69 | +82.47% | 2 | Feb 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $57 → $55 | $27.31 | +101.39% | 2 | Jan 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Underweight | $10 → $3 | $1.22 | +145.90% | 10 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $8 → $11 | $29.91 | -63.22% | 9 | Jun 21, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Equal-Weight | $7 | $2.42 | +189.26% | 18 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $32 | $31.74 | +0.82% | 27 | Mar 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $21 → $19 | $3.74 | +408.02% | 3 | Aug 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $2 → $1 | $2.23 | -55.16% | 3 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Underweight | $13 → $10 | $20.74 | -51.78% | 9 | Mar 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $27 → $8 | $8.90 | -10.11% | 9 | Feb 28, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $57 → $44 | $31.59 | +39.28% | 28 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $13 | $5.13 | +153.41% | 3 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $140 → $80 | $25.47 | +214.10% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $100 → $60 | $5.42 | +1,007.01% | 4 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $203 → $216 | $96.25 | +124.42% | 8 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $7 → $5 | $3.29 | +51.98% | 13 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $7 → $5 | $1.99 | +151.26% | 6 | Jan 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $178 → $182 | $226.08 | -19.50% | 8 | Dec 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $12 → $9 | $24.34 | -63.02% | 13 | Nov 14, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $30 → $40 | $54.55 | -26.67% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $279 → $282 | $329.89 | -14.52% | 38 | Nov 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $220 → $210 | $458.12 | -54.16% | 7 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $55 → $52 | $26.03 | +99.77% | 5 | May 4, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $175 → $173 | $201.93 | -14.33% | 3 | Apr 6, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $156 → $120 | $36.38 | +229.85% | 17 | Feb 1, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $145 → $148 | $9.55 | +1,449.74% | 19 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $88 → $82 | $99.72 | -17.77% | 4 | Nov 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $71 → $66 | $52.15 | +26.56% | 4 | Oct 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $43 → $39 | $5.05 | +672.28% | 4 | Aug 18, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $51 → $46 | $39.73 | +15.78% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $33 → $35 | $7.14 | +390.20% | 1 | Aug 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $207 → $275 | $1,010.31 | -72.78% | 2 | Aug 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $19 | $2.68 | +608.96% | 1 | Jun 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $67 → $62 | $13.16 | +371.12% | 12 | Mar 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $16 → $17 | $16.90 | +2.07% | 3 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $89 → $83 | $102.52 | -19.04% | 1 | Jan 6, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Equal-Weight | $10 | $65.67 | -84.77% | 4 | Sep 10, 2018 |
argenx SE
Dec 4, 2025
Maintains: Overweight
Price Target: $1,070 → $1,110
Current: $901.17
Upside: +23.17%
Pharvaris
Dec 4, 2025
Maintains: Overweight
Price Target: $37 → $41
Current: $26.42
Upside: +55.19%
Regeneron Pharmaceuticals
Dec 3, 2025
Downgrades: Equal-Weight
Price Target: $767
Current: $718.36
Upside: +6.77%
Zentalis Pharmaceuticals
Nov 12, 2025
Maintains: Equal-Weight
Price Target: $8 → $4
Current: $1.39
Upside: +187.77%
BioMarin Pharmaceutical
Oct 28, 2025
Maintains: Overweight
Price Target: $104 → $98
Current: $53.40
Upside: +83.52%
Biogen
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $144 → $149
Current: $181.30
Upside: -17.82%
Moderna
Oct 10, 2025
Maintains: Equal-Weight
Price Target: $31 → $32
Current: $27.70
Upside: +15.52%
Denali Therapeutics
Aug 18, 2025
Maintains: Overweight
Price Target: $33 → $30
Current: $19.96
Upside: +50.30%
Insmed
Aug 13, 2025
Downgrades: Equal-Weight
Price Target: $112 → $126
Current: $204.00
Upside: -38.24%
Legend Biotech
Aug 12, 2025
Maintains: Overweight
Price Target: $81 → $83
Current: $28.13
Upside: +195.06%
Aug 12, 2025
Maintains: Overweight
Price Target: $6 → $4
Current: $0.70
Upside: +474.14%
Aug 5, 2025
Maintains: Equal-Weight
Price Target: $460 → $439
Current: $455.48
Upside: -3.62%
Jul 29, 2025
Maintains: Equal-Weight
Price Target: $15 → $20
Current: $22.26
Upside: -10.15%
Jul 15, 2025
Initiates: Positive
Price Target: $215
Current: $186.39
Upside: +15.35%
Apr 25, 2025
Maintains: Overweight
Price Target: $130 → $135
Current: $121.22
Upside: +11.37%
Apr 11, 2025
Maintains: Equal-Weight
Price Target: $6.2 → $6
Current: $3.17
Upside: +89.27%
Mar 12, 2025
Maintains: Overweight
Price Target: $15 → $5
Current: $1.41
Upside: +254.61%
Feb 21, 2025
Maintains: Buy
Price Target: $160 → $178
Current: $139.33
Upside: +27.75%
Feb 18, 2025
Upgrades: Buy
Price Target: $56
Current: $30.69
Upside: +82.47%
Jan 31, 2025
Maintains: Buy
Price Target: $57 → $55
Current: $27.31
Upside: +101.39%
Nov 26, 2024
Downgrades: Underweight
Price Target: $10 → $3
Current: $1.22
Upside: +145.90%
Jun 21, 2024
Maintains: Equal-Weight
Price Target: $8 → $11
Current: $29.91
Upside: -63.22%
May 9, 2024
Upgrades: Equal-Weight
Price Target: $7
Current: $2.42
Upside: +189.26%
Mar 26, 2024
Maintains: Underweight
Price Target: $32
Current: $31.74
Upside: +0.82%
Aug 14, 2023
Maintains: Equal-Weight
Price Target: $21 → $19
Current: $3.74
Upside: +408.02%
Mar 27, 2023
Maintains: Underweight
Price Target: $2 → $1
Current: $2.23
Upside: -55.16%
Mar 3, 2023
Maintains: Underweight
Price Target: $13 → $10
Current: $20.74
Upside: -51.78%
Feb 28, 2023
Downgrades: Equal-Weight
Price Target: $27 → $8
Current: $8.90
Upside: -10.11%
Feb 27, 2023
Maintains: Equal-Weight
Price Target: $57 → $44
Current: $31.59
Upside: +39.28%
Jan 24, 2023
Maintains: Overweight
Price Target: $15 → $13
Current: $5.13
Upside: +153.41%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $140 → $80
Current: $25.47
Upside: +214.10%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $100 → $60
Current: $5.42
Upside: +1,007.01%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $203 → $216
Current: $96.25
Upside: +124.42%
Jan 24, 2023
Maintains: Equal-Weight
Price Target: $7 → $5
Current: $3.29
Upside: +51.98%
Jan 24, 2023
Maintains: Overweight
Price Target: $7 → $5
Current: $1.99
Upside: +151.26%
Dec 6, 2022
Maintains: Overweight
Price Target: $178 → $182
Current: $226.08
Upside: -19.50%
Nov 14, 2022
Maintains: Equal-Weight
Price Target: $12 → $9
Current: $24.34
Upside: -63.02%
Nov 7, 2022
Maintains: Equal-Weight
Price Target: $30 → $40
Current: $54.55
Upside: -26.67%
Nov 4, 2022
Maintains: Overweight
Price Target: $279 → $282
Current: $329.89
Upside: -14.52%
Oct 28, 2022
Maintains: Equal-Weight
Price Target: $220 → $210
Current: $458.12
Upside: -54.16%
May 4, 2022
Maintains: Equal-Weight
Price Target: $55 → $52
Current: $26.03
Upside: +99.77%
Apr 6, 2022
Maintains: Equal-Weight
Price Target: $175 → $173
Current: $201.93
Upside: -14.33%
Feb 1, 2022
Maintains: Overweight
Price Target: $156 → $120
Current: $36.38
Upside: +229.85%
Jan 7, 2022
Maintains: Equal-Weight
Price Target: $145 → $148
Current: $9.55
Upside: +1,449.74%
Nov 29, 2021
Maintains: Equal-Weight
Price Target: $88 → $82
Current: $99.72
Upside: -17.77%
Oct 12, 2021
Maintains: Equal-Weight
Price Target: $71 → $66
Current: $52.15
Upside: +26.56%
Aug 18, 2021
Maintains: Overweight
Price Target: $43 → $39
Current: $5.05
Upside: +672.28%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $51 → $46
Current: $39.73
Upside: +15.78%
Aug 16, 2021
Maintains: Equal-Weight
Price Target: $33 → $35
Current: $7.14
Upside: +390.20%
Aug 5, 2021
Maintains: Overweight
Price Target: $207 → $275
Current: $1,010.31
Upside: -72.78%
Jun 24, 2021
Initiates: Buy
Price Target: $19
Current: $2.68
Upside: +608.96%
Mar 8, 2021
Maintains: Overweight
Price Target: $67 → $62
Current: $13.16
Upside: +371.12%
Feb 24, 2021
Maintains: Equal-Weight
Price Target: $16 → $17
Current: $16.90
Upside: +2.07%
Jan 6, 2020
Maintains: Equal-Weight
Price Target: $89 → $83
Current: $102.52
Upside: -19.04%
Sep 10, 2018
Assumes: Equal-Weight
Price Target: $10
Current: $65.67
Upside: -84.77%